Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price dropped 2.4% during mid-day trading on Friday . The stock traded as low as GBX 100 ($1.24) and last traded at GBX 102.50 ($1.27). Approximately 42,693 shares were traded during trading, an increase of 2% from the average daily volume of 41,958 shares. The stock had previously closed at GBX 105 ($1.30).
Celadon Pharmaceuticals Stock Down 2.4 %
The company has a market capitalization of £65.82 million and a P/E ratio of -788.46. The company has a current ratio of 1.86, a quick ratio of 6.97 and a debt-to-equity ratio of 153.26. The stock has a 50 day moving average price of GBX 99.32 and a 200 day moving average price of GBX 101.47.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Celadon Pharmaceuticals
- Insider Trading – What You Need to Know
- MarketBeat Week in Review – 4/22 – 4/26
- What is the Hang Seng index?
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is Short Interest? How to Use It
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
